| Gilead Sciences, Inc. | 25,542 | US$3.43M | 4.7% |
| Vertex Pharmaceuticals Incorporated | 7,657 | US$3.43M | 4.7% |
| Amgen Inc. | 9,803 | US$3.3M | 4.5% |
| Regeneron Pharmaceuticals, Inc. | 3,840 | US$2.36M | 3.2% |
| Alnylam Pharmaceuticals, Inc. | 4,904 | US$1.48M | 2.0% |
| Revolution Medicines, Inc. | 7,326 | US$1.15M | 1.6% |
| Biogen Inc. | 5,425 | US$1.06M | 1.4% |
| Illumina, Inc. | 5,653 | US$921K | 1.3% |
| United Therapeutics Corporation | 1,620 | US$902K | 1.2% |
| Royalty Pharma Plc | 15,837 | US$883K | 1.2% |
| Argenx Se | 1,050 | US$878K | 1.2% |
| Insmed Incorporated | 7,968 | US$852K | 1.2% |
| Roivant Sciences Ltd. | 26,460 | US$794K | 1.1% |
| Incyte Corporation | 7,359 | US$712K | 0.97% |
| Viatris Inc. | 42,565 | US$692K | 0.94% |
| Moderna, Inc. | 14,600 | US$689K | 0.94% |
| Guardant Health, Inc. | 4,850 | US$629K | 0.85% |
| Neurocrine Biosciences, Inc. | 3,712 | US$588K | 0.80% |
| Jazz Pharmaceuticals Plc | 2,275 | US$538K | 0.73% |
| Ascendis Pharma A/s | 2,276 | US$510K | 0.69% |
| Summit Therapeutics Inc. | 28,664 | US$503K | 0.68% |
| Exelixis, Inc. | 9,600 | US$485K | 0.66% |
| Bridgebio Pharma, Inc. | 7,167 | US$475K | 0.64% |
| Medpace Holdings, Inc. | 1,051 | US$470K | 0.64% |
| Ionis Pharmaceuticals, Inc. | 6,109 | US$467K | 0.63% |
| Axsome Therapeutics, Inc. | 1,890 | US$443K | 0.60% |
| Madrigal Pharmaceuticals, Inc. | 847 | US$421K | 0.57% |
| Biomarin Pharmaceutical Inc. | 7,110 | US$407K | 0.55% |
| Arrowhead Pharmaceuticals, Inc. | 5,178 | US$403K | 0.55% |
| Sanofi Sa | 4,540 | US$395K | 0.54% |
| Praxis Precision Medicines, Inc. | 1,029 | US$360K | 0.49% |
| Cytokinetics, Incorporated | 4,553 | US$349K | 0.47% |
| Beone Medicines Ltd. Class A | 1,181 | US$340K | 0.46% |
| Krystal Biotech, Inc. | 1,080 | US$334K | 0.45% |
| Tempus Ai, Inc. | 6,424 | US$324K | 0.44% |
| Abivax Sa | 2,271 | US$301K | 0.41% |
| Nuvalent, Inc. | 2,705 | US$299K | 0.41% |
| Halozyme Therapeutics, Inc. | 4,364 | US$290K | 0.39% |
| Immunitybio, Inc. | 38,008 | US$286K | 0.39% |
| Vaxcyte, Inc. | 5,321 | US$273K | 0.37% |
| Alkermes Plc | 6,163 | US$260K | 0.35% |
| Immunovant, Inc. | 7,523 | US$251K | 0.34% |
| Kymera Therapeutics, Inc. | 3,017 | US$246K | 0.33% |
| Protagonist Therapeutics, Inc. | 2,361 | US$235K | 0.32% |
| Mirum Pharmaceuticals, Inc. | 2,231 | US$226K | 0.31% |
| Ptc Therapeutics, Inc. | 3,062 | US$226K | 0.31% |
| Rhythm Pharmaceuticals, Inc. | 2,526 | US$223K | 0.30% |
| Spyre Therapeutics, Inc. | 2,905 | US$214K | 0.29% |
| Cogent Biosciences, Inc. | 6,002 | US$210K | 0.28% |
| Crispr Therapeutics Ag | 3,550 | US$199K | 0.27% |
| Cg Oncology, Inc. | 3,123 | US$195K | 0.26% |
| Scholar Rock Holding Corporation | 3,773 | US$186K | 0.25% |
| Caris Life Sciences, Inc. | 10,431 | US$174K | 0.24% |
| Ligand Pharmaceuticals Incorporated | 736 | US$171K | 0.23% |
| Xenon Pharmaceuticals Inc. | 3,074 | US$168K | 0.23% |
| Apogee Therapeutics, Inc. | 2,028 | US$167K | 0.23% |
| Indivior Pharmaceuticals, Inc. | 4,624 | US$167K | 0.23% |
| Travere Therapeutics, Inc. | 3,409 | US$161K | 0.22% |
| Amneal Pharmaceuticals, Inc. | 11,632 | US$153K | 0.21% |
| Twist Bioscience Corporation | 2,266 | US$152K | 0.21% |
| Erasca, Inc. | 11,444 | US$147K | 0.20% |
| Newamsterdam Pharma Company N.v. | 4,252 | US$143K | 0.19% |
| Crinetics Pharmaceuticals, Inc. | 3,872 | US$138K | 0.19% |
| Acadia Pharmaceuticals Inc. | 6,303 | US$137K | 0.19% |
| Veracyte, Inc. | 2,938 | US$136K | 0.18% |
| Edgewise Therapeutics, Inc. | 3,966 | US$135K | 0.18% |
| Beam Therapeutics Inc. | 3,767 | US$124K | 0.17% |
| Denali Therapeutics Inc. | 5,863 | US$123K | 0.17% |
| 10x Genomics, Inc. | 4,351 | US$123K | 0.17% |
| Dyne Therapeutics, Inc. | 6,087 | US$118K | 0.16% |
| Tango Therapeutics, Inc. | 4,978 | US$109K | 0.15% |
| Oruka Therapeutics, Inc. | 1,789 | US$105K | 0.14% |
| Grail, Inc. | 1,439 | US$103K | 0.14% |
| Alumis Inc. | 4,674 | US$101K | 0.14% |
| Arcutis Biotherapeutics, Inc. | 4,587 | US$98,437 | 0.13% |
| Disc Medicine, Inc. | 1,411 | US$98,163 | 0.13% |
| Supernus Pharmaceuticals, Inc. | 2,120 | US$97,902 | 0.13% |
| Ideaya Biosciences, Inc. | 3,246 | US$95,660 | 0.13% |
| Vera Therapeutics, Inc. | 2,636 | US$93,631 | 0.13% |
| Tarsus Pharmaceuticals, Inc. | 1,573 | US$93,436 | 0.13% |
| Relay Therapeutics, Inc. | 6,606 | US$92,814 | 0.13% |
| Mineralys Therapeutics, Inc. | 2,925 | US$92,138 | 0.13% |
| Definium Therapeutics, Inc. | 3,685 | US$89,140 | 0.12% |
| Enliven Therapeutics, Inc. | 2,196 | US$86,896 | 0.12% |
| Adaptive Biotechnologies Corporation | 5,692 | US$86,234 | 0.12% |
| Ultragenyx Pharmaceutical Inc. | 3,571 | US$85,490 | 0.12% |
| Kodiak Sciences Inc | 2,255 | US$82,781 | 0.11% |
| Biocryst Pharmaceuticals, Inc. | 9,271 | US$82,605 | 0.11% |
| Kiniksa Pharmaceuticals International, Plc | 1,698 | US$82,149 | 0.11% |
| Aurinia Pharmaceuticals Inc | 4,914 | US$75,332 | 0.10% |
| Ocular Therapeutix, Inc. | 8,049 | US$72,521 | 0.10% |
| Novocure Limited | 4,209 | US$71,721 | 0.10% |
| Pharvaris N.v. | 2,367 | US$71,389 | 0.10% |
| Sionna Therapeutics, Inc. | 1,651 | US$70,696 | 0.10% |
| Adma Biologics Inc | 8,805 | US$70,264 | 0.10% |
| Rapport Therapeutics, Inc. | 1,764 | US$69,678 | 0.09% |
| Zymeworks Inc. | 2,766 | US$69,510 | 0.09% |
| Recursion Pharmaceuticals, Inc. | 19,297 | US$69,276 | 0.09% |
| Sarepta Therapeutics, Inc. | 3,875 | US$69,246 | 0.09% |
| Abcellera Biologics Inc. | 11,209 | US$69,160 | 0.09% |